Phase 2 Ectasia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary hemorrhagic telangiectasia
Alnylam Pharmaceuticals120 enrolled16 locationsNCT06659640
Recruiting
Phase 2
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Telangiectasia, Hereditary Hemorrhagic
Dr. Romain Lazor48 enrolled3 locationsNCT04976036
Recruiting
Phase 2
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
Corneal EctasiaKeratoconusPellucid Marginal Corneal Degeneration
Goodman Eye Center500 enrolled1 locationNCT04094090
Recruiting
Phase 2Phase 3
Comparison of Standard vs. Accelerated Corneal Crosslinking
KeratoconusEctasia Corneal
Price Vision Group510 enrolled1 locationNCT03922542